DG Guide
By Beatriz Manzor Mitrzyk
CHICAGO -- Results of a 1-year, randomised, controlled trial show that dimebolin hydrochloride can improve cognition, function, and behaviour in patients with mild or moderate Alzheimer's disease (AD).
Rachelle Doody, MD, PhD, Baylor College of Medicine, Houston, Texas, presented the findings on May 1 at the 2009 Annual Scientific Meeting of the American Geriatrics Society (AGS).
Dimebolin, an oral antihistamine used in Russia since 1983, is a small molecule that appears to inhibit brain cell death by enhancing mitochondrial function, increasing cell viability, and promoting neurite growth. Dimebolin is under investigation in the United States for the treatment for neurodegenerative disorders like AD.
In this 1-year, double-blind, placebo......read the whole article
For a great resource for those with dementia, caregivers and healthcare professinals, click here
For information on being the best caregiver you can be, click here
For more interesting dementia articles and activities, click here
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment